Ernexa Therapeutics (ERNAW) Tax Rate (2010 - 2026)

Ernexa Therapeutics has reported Tax Rate for 17 years, with the latest figure at 0.72% in Q1 2026.

• For the quarter ending Q1 2026, Tax Rate rose 82.0% year-over-year to 0.72%; the trailing twelve-month figure through Mar 2026 stood at 0.39% (up 85.0% YoY), and the FY2025 full-year result was 0.02%, down 1502.0% from the prior year.
• Tax Rate for Q1 2026 stood at 0.72%, down from 0.9% in the prior quarter.
• The five-year high for Tax Rate was 0.9% in Q4 2025, with the low at 0.49% in Q3 2025.
• Historically, Tax Rate has averaged 0.05% across 5 years, with a median of 0.05% in 2024.
• The largest YoY upside for Tax Rate was 94 bps in 2025 against a maximum downside of 44 bps in 2025.
• Ernexa Therapeutics' Tax Rate stood at 0.02% in 2022, then soared by 190 bps to 0.07% in 2023, then sank by 163 bps to 0.04% in 2024, then jumped by 2270 bps to 0.9% in 2025, then declined by 19 bps to 0.72% in 2026.
• The last three Tax Rate figures came in at 0.72% (Q1 2026), 0.9% (Q4 2025), and 0.49% (Q3 2025), per Business Quant data.